General Skin Cancer

Coffee Might Reduce the Risk of Basal Cell Carcinoma (07-11-2012)

Good news for coffee lovers—drinking caffeinated coffee could lower the risk of developing basal cell carcinoma, according to the results of a study published in Cancer Research. The Harvard study found that increased caffeine intake was associated... Continue Reading

Erivedge Effective in Basal-Cell Carcinoma (06-21-2012)

The targeted agent Erivedge™ (vismodegib) is associated with tumor responses in patients with locally advanced or metastatic basal-cell carcinoma and may even reduce the rate of new basal-cell carcinomas, according to the results of two studies published... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (03-26-2012)

A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading

Erivedge Approved for Basal Cell Skin Cancer (02-1-2012)

The US Food and Drug Administration (FDA) has approved the targeted therapy Erivedge™ (vismodegib) for the treatment basal cell carcinoma of the skin that has spread to other parts of the body or that is locally advanced and cannot be treated with surgery... Continue Reading

Increased Skin Cancer Risk Among Those with Inflammatory Bowel Disease (11-29-2011)

People with inflammatory bowel disease (IBD) may be at increased risk of non-melanoma skin cancer, particularly if they receive immune-suppressing medications such as thiopurines. These were the results of two studies published in Gastroenterology. Crohn’s... Continue Reading

Additional Evidence That Tanning Beds Increase Skin Cancer Risk (11-3-2011)

According to a study of more than 73,000 women, use of tanning beds increases the risk of three common types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melanoma. These results were presented at the 10th AACR International Conference... Continue Reading

Vismodegib Shrinks Advanced Basal Cell Skin Cancers (10-6-2011)

The investigational targeted therapy vismodegib (GDC-0449) may provide a significant benefit to patients with locally advanced or metastatic basal cell skin cancers. The results of this Phase II clinical trial were presented at the 2011 European Multidisciplinary... Continue Reading

Erbitux Shows Promise Against Squamous Cell Skin Cancer (08-3-2011)

Among elderly patients with squamous cell skin cancer that could not be surgically removed, treatment with the targeted therapy Erbitux® (cetuximab) produced a promising rate of disease control. The results of this Phase II clinical trial were published... Continue Reading

Stay on Top of Your Family History of Cancer (07-15-2011)

People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s important to update this information periodically... Continue Reading

No Clear Role for Selenium in Cancer Prevention (05-17-2011)

Some studies have suggested that people with higher selenium levels have a lower risk of certain types of cancer; a review conducted by the Cochrane Collaboration, however, found no clear evidence that selenium supplements provide a cancer benefit. Selenium... Continue Reading

« Previous PageNext Page »